According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer,...

TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.

Each year, floods and riverbank erosion, particularly in northern Bangladesh, impact millions of people, leading to significant loss of lives and...

Each year, floods and riverbank erosion, particularly in northern Bangladesh, impact millions of people, leading to significant loss of lives and...

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and...

The FDA approves NVS' Kisqali to reduce the risk of disease recurrence in patients with HR+/HER2- early breast cancer.

Researchers at The University of Queensland are developing a comprehensive paediatric immune cell ‘atlas’ to aid in the diagnosis and treatment of...

People in the Philippines can now receive leading-edge, clinical care recommendations from City of Hope cancer specialists LOS ANGELES — Oncology...

Breast cancer remains one of the most common cancers affecting women worldwide, but early detection and education can make all the difference in...